Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial
published in: Annals of Internal Medicine
date of publication: 2011-11-01
language: English
main subject: patient, dabigatran, atrial fibrillation, (RS)-warfarin
Cites articles
There is nothing here
Article - wd:Q44446438